Servicio de Medicina Intensiva, Hospital Universitario de Getafe, Getafe, Madrid, España; Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Madrid, España.
Servicio de Medicina Intensiva, Hospital Universitario de Getafe, Getafe, Madrid, España.
Med Clin (Barc). 2022 Jan 21;158(2):58-64. doi: 10.1016/j.medcli.2020.11.035. Epub 2021 Jan 27.
Critical patients, despite initial recovery in the intensive care unit (ICU), may require readmission to the ICU or even die in the same hospital episode. The objectives are to determine the incidence and to identify risk factors for ICU readmission, and to determine hospital mortality.
Observational cohort study of all patients admitted consecutively for more than 24hours to the ICU of the University Hospital of Getafe between April 1, 2018 and September 30, 2018 and discharged alive from their first ICU admission.
Of the 164 patients alive at ICU discharge, 14 (8.5%) were readmitted to ICU (2.4% at≤48hours). The adjusted risk of ICU readmission was higher in patients with disabling neurological deficits prior to ICU admission [odds ratio (OR) 7.96, 95% confidence interval (CI) 1.55-40.92] or who received vasoactive drugs (OR 5.07, 95% CI 1.41-18.29) during their ICU stay. Readmitted patients had higher hospital mortality (4 of 14 [29%] versus 5 of 150 [3%], P<.001) and longer hospital stay (74.5 [37.5-99.75] days versus 16 [9-34] days, median [interquartile range], P=.001).
Patients with disabling neurological deficits prior to hospital admission or who received vasoactive drugs during their ICU stay have a higher risk of readmission to the ICU, which increases hospital stay and mortality.
尽管重症监护病房(ICU)的患者在初期恢复后,仍可能需要再次入住 ICU,甚至在同一住院期间死亡。本研究旨在确定 ICU 再入院的发生率和相关危险因素,并确定医院死亡率。
本研究为 2018 年 4 月 1 日至 9 月 30 日期间连续入住马德里戈塔菲大学医院 ICU 且首次 ICU 出院时存活的所有患者的观察性队列研究。
在 ICU 出院时存活的 164 名患者中,有 14 名(8.5%)再次入住 ICU(48 小时内再次入住 ICU 的比例为 2.4%)。入住 ICU 前存在神经功能障碍残疾的患者(优势比 [OR] 7.96,95%置信区间 [CI] 1.55-40.92)或在 ICU 期间使用血管活性药物的患者(OR 5.07,95% CI 1.41-18.29)再次入住 ICU 的风险更高。再次入住 ICU 的患者的医院死亡率更高(14 名中的 4 名 [29%]与 150 名中的 5 名 [3%],P<.001),且住院时间更长(74.5 [37.5-99.75]天与 16 [9-34]天,中位数[四分位距],P=.001)。
入住 ICU 前存在神经功能障碍残疾或在 ICU 期间使用血管活性药物的患者再次入住 ICU 的风险更高,这会增加住院时间和死亡率。